| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.89B | +13.2% |
| Cost of Revenue | $1.53B | +1.7% |
| Gross Profit | $359.3M | +117.9% |
| R&D Expense | $14.0M | -22.2% |
| SG&A Expense | $225.6M | +6.8% |
| Operating Income | $122.9M | +319.5% |
| Pre-tax Income | $149.6M | +305.2% |
| Income Tax | $63.4M | +366.4% |
| Net Income | $86.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $106.7M | -45.2% |
| Accounts Receivable | $291.0M | -1.4% |
| Inventory | $656.7M | +16.3% |
| Current Assets | $1.11B | -1.1% |
| Total Assets | $1.91B | +4.1% |
| Current Liabilities | $476.6M | +28.5% |
| Long-term Debt | $507.4M | +15.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $72.5M | +1218.2% |
| Capital Expenditures | $29.5M | -37.8% |
| Investing Cash Flow | -$186.3M | -293.0% |
| Financing Cash Flow | $26.5M | +128.9% |
| Free Cash Flow | $43.0M | +202.6% |
| +275.6% |
| EPS (Basic) | $0.75 | +274.4% |
| EPS (Diluted) | $0.75 | +274.4% |
| Stockholders' Equity |
| $817.0M |
| +1.1% |